All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 265–288 of 416 in Industry & Access

Apr 7, 2026globenewswire.com

Speke AI to Showcase Ambient AI Solutions at UCA’s 2026 Urgent Care Convention

generalIndustry & Access

Apr 7, 2026longevity.technology

Cymbiotika partners with Gary Brecka for precision wellness

generalIndustry & Access

Apr 7, 2026globenewswire.com

Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer

generalIndustry & Access

Apr 7, 2026globenewswire.com

Liquidia Corporation to Participate in Upcoming Investor Conferences

generalIndustry & Access

Apr 7, 2026globenewswire.com

Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health

generalIndustry & Access

Apr 7, 2026globenewswire.com

OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting

generalIndustry & Access

Apr 7, 2026globenewswire.com

Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program

generalIndustry & Access

Apr 7, 2026longevity.technology

Generare bags $21.6m for nature-derived drug leads

generalIndustry & Access

Apr 7, 2026longevity.technology

Allergan Aesthetics finds its next growth engine in GLP-1s

significantIndustry & Access

Apr 7, 2026globenewswire.com

Influenza Vaccine Market Forecast 2031: Quadrivalent Vaccines Held 71.68% Share in 2025, Says a Mordor Intelligence Report

generalIndustry & Access

Apr 7, 2026globenewswire.com

SonoNeu exits stealth as key part of US Government-funded research program worth up to $41.3m to advance sonogenetics into clinic

generalIndustry & Access

Apr 7, 2026globenewswire.com

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

generalIndustry & Access

Apr 7, 2026globenewswire.com

Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale

generalIndustry & Access

Apr 7, 2026globenewswire.com

Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

generalIndustry & Access

Apr 6, 2026fiercebiotech.com

Takeda tears up Denali partnership, returning dementia asset amid restructuring

significantIndustry & Access

Apr 6, 2026globenewswire.com

MISTR Covers Florida Patients as ADAP Changes Create Gaps in HIV Treatment Access

generalIndustry & Access

Apr 6, 2026fiercebiotech.com

Anthropic acquires stealth AI startup Coefficient Bio in $400M deal: reports

generalIndustry & Access

Apr 6, 2026fiercebiotech.com

US, UK regulators bolster medical device collaboration while lifting tariffs

significantIndustry & Access

Apr 6, 2026globenewswire.com

Yuzu Health Raises $35 Million Series A to Modernize Health Insurance Plan Infrastructure

generalIndustry & Access

Apr 6, 2026globenewswire.com

HairClub Launches $100,000 Aderans Helping Hearts Fund to Support Employees Facing Life’s Unexpected Hardships

generalIndustry & Access

Apr 6, 2026globenewswire.com

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

generalIndustry & Access

Apr 6, 2026longevity.technology

WELL Health partners with AliveCor for cardiac monitoring in Canada

generalIndustry & Access

Apr 6, 2026globenewswire.com

$9.66+ BN Gastroenterology Products Market Forecasts to 2034: Rising aging population, advancing endoscopic tech, and expanding healthcare in developing regions

generalIndustry & Access

Apr 6, 2026fightaging.org

A Review Focused on Exerkines in Extracellular Vesicles Generated by Muscle Tissue

generalIndustry & Access